• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, August 18, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Medications: As many as needed, as few as possible!

Bioengineer by Bioengineer
February 26, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

New endowed chair for polypharmacy and health services research at Goethe University

Marjan van den Akker worked at the Maastricht University (Netherlands) and is an internationally recognised expert in the field of multimorbidity and polypharmacy. From 1st March, she will start projects to enhance medication prescriptions to patients with multimorbidity (co-occurring diseases) in cooperation with doctors, pharmacists, scientists and nurse practitioners. The chair has been endowed for a period of six years by INSIGHT Health, a company that specialises in the analysis of medical prescriptions.

“Older patients in particular, but younger patients as well, are affected by multimorbidity. They usually have a complex health situation that can be quite challenging for doctors,” says Professor van den Akker. Her research focuses on frequent disease combinations and their medical treatment. She wants to improve the care for these patients by the further development and evaluation of interventions.

Previous studies have shown that for many patients with multimorbidity, overall prescriptions can be improved either by reducing medications, or sometimes by prescribing additional medication. “It’s important to me to take the preferences and living circumstances of the patients into account. The benefits and risks of medication need to be discussed with their doctor, and a decision then reached together.”

In view of the frequency and complexity of polypharmacy, Professor van den Akker desires to educate both medical and pharmaceutical students in caring for this patient group. She plans to set up an interdisciplinary teaching programme offering joint classes for future doctors and future pharmacists.

Prof. Ferdinand Gerlach, Director of the Institute of General Practice, is happy with the new chair. “The new endowed chair is a perfect fit for our research profile in Frankfurt. With Professor van Akker, we can develop new paths for improving health care for the chronically ill and support general practitioners in their important work even better.”

Professor Pfeilschifter, Dean of the Faculty of Medicine, adds: “Medication research and medication therapy are a focal point of the Faculty of Medicine and of Goethe University overall. As such Professor van den Akker is an excellent choice and she complements the dynamic field of Medicine at Goethe University.”

###

Further information: Prof. Dr. Marjan van den Akker, Institute of General Practice, Campus Niederrad, Tel.: +49 69 6301-80454/-5930; [email protected]

Current news about science, teaching, and society in GOETHE-UNI online

Goethe University is a research-oriented university in the European financial centre Frankfurt The university was founded in 1914 through private funding, primarily from Jewish sponsors, and has since produced pioneering achievements in the areas of social sciences, sociology and economics, medicine, quantum physics, brain research, and labour law. It gained a unique level of autonomy on 1 January 2008 by returning to its historic roots as a “foundation university”. Today, it is one of the three largest universities in Germany. Together with the Technical University of Darmstadt and the University of Mainz, it acts as a partner of the inter-state strategic Rhine-Main University Alliance. Internet: http://www.uni-frankfurt.de

Publisher: The President of Goethe University Editor: Dr. Anne Hardy, Referee for Science Communication, PR & Communication Department, Theodor-W.-Adorno-Platz 1, 60323 Frankfurt am Main, Tel: (069) 798-13035, Fax: (069) 798-763 12531.

Media Contact
Marjan van den Akker
[email protected]
https://aktuelles.uni-frankfurt.de/englisch/new-endowed-chair-for-polypharmacy-and-health-services-research-at-goethe-university/

Tags: Health Care Systems/ServicesHealth ProfessionalsMedicine/HealthPharmaceutical SciencePublic Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Promising Outcomes from Phase I/II Gene Therapy Trial for GM2 Gangliosidosis, Including Tay-Sachs and Sandhoff Diseases

Promising Outcomes from Phase I/II Gene Therapy Trial for GM2 Gangliosidosis, Including Tay-Sachs and Sandhoff Diseases

August 18, 2025
DENND1A Drives Testosterone in Polycystic Ovary Syndrome

DENND1A Drives Testosterone in Polycystic Ovary Syndrome

August 18, 2025

Mitochondrial Antioxidant Identified as Key Driver of Breast Cancer Metastasis

August 18, 2025

eIF2B Activator DNL343 Targets ALS and TDP-43

August 18, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    141 shares
    Share 56 Tweet 35
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    80 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    59 shares
    Share 24 Tweet 15
  • Predicting Colorectal Cancer Using Lifestyle Factors

    47 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Two Prestigious Grants Empower Young Investigator to Advance Blood Cancer Research

SwRI Study Validates Long-Standing Theoretical Models of Solar Reconnection

Revolutionary Self-Powered Patch Monitors Biomarkers Non-Invasively, Eliminating the Need for Blood Draws

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.